Trigeminal Neuralgia

Detailed Overview

Considered one of the most painful conditions known to medicine, TN drastically impacts quality of life, often leading to severe weight loss (due to pain when eating) and profound depression or suicidality. The pain occurs in paroxysms lasting from a fraction of a second to two minutes. It is almost always strictly unilateral. The attacks are typically triggered by innocuous mechanical stimuli to the face, such as washing, shaving, chewing, or even a light breeze.

Epidemiology & Demographics

Incidence is roughly 4-5 per 100,000 population per year. It is more common in women (ratio 1.5:1) and predominantly affects individuals over the age of 50. If presenting in a young patient (e.g., 20s-30s), it highly suggests an underlying demyelinating disease like Multiple Sclerosis.

Etiological Mechanism

The majority of classical TN cases (80-90%) are caused by vascular compression of the trigeminal nerve root entry zone by an aberrant loop of an artery or vein. Secondary TN can be caused by Multiple Sclerosis (demyelinating plaques), cerebellopontine angle tumors (vestibular schwannoma, meningioma), or arteriovenous malformations.

Primary Causes

Classical: Neurovascular compression, most commonly by the Superior Cerebellar Artery (SCA) compressing the nerve root. Secondary: Multiple Sclerosis, tumors, or physical trauma/dental procedures.

• Age: Increasing age (>50 years) leads to elongation and sagging of cerebral arteries, increasing the chance of nerve compression.
• Multiple Sclerosis: Patients with MS have a significantly higher risk of TN due to demyelinating plaques at the root entry zone.
• Hypertension: Chronically elevated blood pressure alters vascular compliance, potentially worsening vascular loops.

Chronic mechanical compression by a blood vessel at the trigeminal nerve root entry zone (near the pons) causes localized focal demyelination. This demyelination disrupts the insulating myelin sheath, allowing ephaptic transmission ('short-circuiting') between adjacent nerve fibers. Touch/vibration signals traveling via heavily myelinated A-beta fibers jump to unmyelinated pain fibers (A-delta and C fibers). Furthermore, the damaged nerve becomes hyper-excitable, leading to spontaneous generation of ectopic action potentials. The brain interprets these intense, spontaneous volleys as severe facial pain.

Characteristic Clinical Presentation

• Lancinating Pain: Sudden, severe, stabbing, or electric-shock-like pain that peaks instantly.
• Triggered Pain: Pain is provoked by light touch, chewing, talking, brushing teeth, or cold wind on the face.
• Refractory Period: A pain-free interval immediately following an attack where a trigger cannot provoke another attack.
• Facial Spasm: Involuntary grimacing of the face in response to the severe pain (hence the term 'tic douloureux').

Physical Examination Signs

• Trigger Zones
• Normal Neurological Exam

• Severe Weight Loss: Avoidance of eating or drinking due to chewing triggering severe pain, leading to dehydration and malnutrition.
• Depression and Suicidality: The unpredictable and agonizing nature of the pain takes a severe psychological toll.
• Dental Extractions: Patients often mistakenly attribute the pain to toothache and undergo multiple unnecessary dental extractions before TN is diagnosed.

Diagnostic Criteria & Guidelines

Clinical diagnosis based on the International Classification of Headache Disorders (ICHD-3). Criteria: 1) Recurrent paroxysms of unilateral facial pain in trigeminal distribution. 2) Pain is lasting fraction of a second to 2 minutes, severe intensity, electric shock-like. 3) Precipitated by innocuous stimuli to affected side. 4) No other neurological deficit. Brain MRI is required in all patients to rule out secondary causes.

Differential Diagnosis

• Dental Pathology (abscess, cracked tooth)
• Temporomandibular Joint (TMJ) Dysfunction
• Glossopharyngeal Neuralgia (pain in throat/base of tongue, triggered by swallowing)
• Postherpetic Neuralgia (continuous burning pain, history of shingles rash)
• Cluster Headache

Laboratory Tests & Biomarkers

• Routine Bloodwork: Normal. Used primarily to establish baselines before starting anticonvulsant therapy (e.g., checking CBC, LFTs, and sodium).

Imaging Modalities & Findings

• MRI Brain with Contrast (Fiesta/CISS sequence): A high-resolution T2-weighted sequence can visualize the trigeminal nerve exiting the brainstem and often demonstrates an offending vascular loop compressing the nerve root entry zone. Rules out MS plaques and cerebellopontine angle tumors.

• Classical TN
  Purely paroxysmal pain with no underlying neurological deficit; caused by vascular compression.
• Secondary TN
  Caused by an underlying disease (MS, tumor). May have continuous background pain and objective sensory loss.
• Idiopathic TN
  Typical symptoms but no vascular compression or underlying cause identified on MRI.

Second-Line & Adjunctive Therapy

If first-line fails or side effects (dizziness, ataxia) are intolerable, use Baclofen, Gabapentin, Pregabalin, or Lamotrigine as add-on therapy or monotherapy. If medical therapy fails entirely, surgical intervention is indicated.

Surgical & Procedural Management

Microvascular Decompression (MVD) is the most definitive and durable surgery. A craniotomy is performed, and a Teflon sponge is placed between the offending artery and the trigeminal nerve. Alternative ablative procedures (for older/frail patients) include Gamma Knife Radiosurgery, percutaneous glycerol rhizotomy, or radiofrequency thermocoagulation.

Recommended Lifestyle Changes

• Use a soft toothbrush and rinse with lukewarm (not cold or hot) water to avoid triggering pain.
• Eat soft foods and chew on the unaffected side of the mouth.
• Protect the face from cold wind using scarves.

Patient Counseling & Advice

Warn patients on Carbamazepine/Oxcarbazepine about the risk of drowsiness, dizziness, and the rare but serious risk of Stevens-Johnson syndrome (especially in Asian patients with HLA-B*1502). Emphasize the importance of regular blood tests to monitor sodium levels (hyponatremia risk) and liver function.

Follow-Up & Monitoring Schedule

Frequent follow-up initially to titrate medications to effective pain control. Monitor basic metabolic panel (specifically serum sodium for Oxcarbazepine-induced SIADH), complete blood count (agranulocytosis risk with Carbamazepine), and liver function tests every 3-6 months.

Preventive Strategies

No known lifestyle modifications can prevent the onset of trigeminal neuralgia.

Variable. Medical therapy is initially effective in up to 80% of patients, but tolerance or severe side effects often develop over years. Microvascular decompression provides long-term pain relief (cure) in 70-80% of cases, though recurrence is possible.